New Recommendations to Eliminate Racial Bias in Blood Cancer Trials by Colleen Fleiss on February 18, 2021 at 11:12 PM
New recommendations are being designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites, said researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR).
Researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR) are releasing recommendations designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites.
Elderly Esophageal Cancer Patients Receive Suboptimal Therapy by Angela Mohan on February 10, 2021 at 2:25 PM
Patients aged above 70 years with locally advanced esophageal (E) and esophagogastric junction (EGJ) cancer should be provided with optimal therapy that has the potential to cure, which includes initial chemoradiotherapy (NACR) and surgical resection.
According to researchers, this recommended therapy is often not offered to elderly patients out of concern that they will not tolerate such an intensive treatment regimen.
In a new study, they found that older patients who received the therapy had outcomes comparable with those of younger patients (under 70 years old).
Journal of the American College of Surgeons in advance of print.
Role of Biomarkers In Assessing Renal Injury in Cancer Patients by Angela Mohan on February 4, 2021 at 11:03 AM
Kidney International Reports. Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer, says Sandra Herrmann, M.D., a Mayo Clinic nephrologist and the study s senior author. In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.
Dr. Herrmann says a kidney biopsy is the gold standard to diagnose this condition. However, a kidney biopsy is an invasive procedure that some patients may not be able to undergo because of the risk of bleeding.
Over 56% Cancer Survivors Associated With Severe Covid-19 Illness by Hannah Joy on February 3, 2021 at 8:12 PM
In the United States, more than half (56.4%) of cancer survivors have additional underlying medical conditions associated with severe COVID-19 illness.
The report appearing in JNCI: The Journal of the National Cancer Institute, suggests that prevalence of these conditions among cancer survivors is nearly 40% higher than that in the general population.
Cancer, and other underlying medical conditions, including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, are associated with increased risk of severe COVID-19 illness.
For this study, investigators Changchuan (Charles) Jiang, MD, PhD, Roswell Park Comprehensive Cancer Center, Xuesong Han, PhD, American Cancer Society, and colleagues used data from the 2016-2018 National Health Interview Survey (NHIS), a national cross-sectional survey of the ci
Heart Health During Covid-19 Needs to Improve Care And Quality by Hannah Joy on February 1, 2021 at 11:28 PM
An intervention to enable rural primary care teams is needed to improve the cardiovascular health of patients with atherosclerotic cardiovascular disease (ASCVD), as the needs and resources available to rural patients with heart disease are different than their urban and suburban counterparts.
The American College of Cardiology s Cardiovascular Summit will feature several poster presentations on care delivery, cost reduction and quality improvement that offer innovative concepts to combat access to care, especially during the ongoing COVID-19 pandemic and as the broader health care system works to improve health equity. Research examines the rapid adoption of virtual outpatient care, enabling rural primary care teams to improve cardiovascular health and optimizing emergency room use after clinic hours.